Catechol O-Methyltransferase Val158Met Polymorphism is Associated with Cognitive Performance in Nondemented Adults

The catechol O-methyltransferase (COMT) gene is essential in the metabolic degradation of dopamine in the prefrontal cortex. In the present study, we examined the effect of a Val158Met polymorphism in the COMT gene on individual differences and changes in cognition (executive functions and visuospatial ability) in adulthood and old age. The participants were 292 nondemented men (initially aged 35-85 years) from a random sample of the population (i.e., the Betula study) tested at two occasions with a 5-year interval. Confirmatory factor analyses were used to test the underlying structure of three indicators of executive functions (verbal fluency, working memory, and Tower of Hanoi). Associations between COMT, age, executive functioning, and visuospatial (block design) tasks were examined using repeated-measures analyses of variance. Carriers of the Val allele (with higher enzyme activity) compared with carriers of the Met/Met genotype (with low enzyme activity) performed worse on executive functioning and visuo-spatial tasks. Individuals with the Val/Val genotype declined in executive functioning over the 5-year period, whereas carriers of the Met allele remained stable in performance. An Age COMT interaction for visuospatial ability located the effect for middle-aged men only. This COMT polymorphism is a plausible candidate gene for executive functioning and fluid intelligence in nondemented middle-aged and older adults.

[1]  P. Rabbitt,et al.  A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: Implications for theories of executive functioning and cognitive aging , 1998, Journal of the International Neuropsychological Society.

[2]  C. Benkelfat,et al.  Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. , 2002, Archives of general psychiatry.

[3]  M. Egan,et al.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Egan,et al.  NEUROBIOLOGY OF SCHIZOPHRENIA AND THE ROLE OF ATYPICAL ANTIPSYCHOTICS Prefrontal Neurons and the Genetics of Schizophrenia , 2001 .

[5]  M. Lezak.  Neuropsychological assessment, 3rd ed. , 1995 .

[6]  A. Grace,et al.  The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes , 2004, Neuropsychopharmacology.

[7]  Lars-Göran Nilsson,et al.  COMT Gene Polymorphism Is Associated with Declarative Memory in Adulthood and Old Age , 2004, Behavior genetics.

[8]  R. Weinshilboum,et al.  Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.

[9]  I. Ulmanen,et al.  Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.

[10]  P. Schlattmann,et al.  Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing , 2003, Biological Psychiatry.

[11]  L. Nyberg,et al.  Betula: A Prospective Cohort Study on Memory, Health and Aging , 2004 .

[12]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  F. Craik,et al.  The Effect of Divided Attention on Encoding and Retrieval in Episodic Memory Revealed by Positron Emission Tomography , 2000, Journal of Cognitive Neuroscience.

[14]  Yves Burnod,et al.  An integrative theory of the phasic and tonic modes of dopamine modulation in the prefrontal cortex , 2002, Neural Networks.

[15]  A. Baddeley,et al.  Attention and retrieval from long-term memory. , 1984 .

[16]  P. Arner,et al.  Large‐scale genotyping of single nucleotide polymorphisms by Pyrosequencing™ and validation against the 5′nuclease (Taqman®) assay , 2002 .

[17]  D. Wechsler.  Manual for the Wechsler Adult Intelligence Scale. , 1955 .

[18]  J. Lieberman,et al.  Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia , 2002, Biological Psychiatry.

[19]  L. Bäckman,et al.  The role of dopamine systems in cognitive aging , 2005 .

[20]  Elizabeth A. Kensinger,et al.  What Neural Correlates Underlie Successful Encoding and Retrieval? A Functional Magnetic Resonance Imaging Study Using a Divided Attention Paradigm , 2003, The Journal of Neuroscience.

[21]  Shih-Jen Tsai,et al.  Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females , 2003, Neuroscience Letters.

[22]  R. Cabeza,et al.  Imaging Cognition II: An Empirical Review of 275 PET and fMRI Studies , 2000, Journal of Cognitive Neuroscience.

[23]  Ronald T. Borchardt,et al.  [34] Catechol O-methyltransferase , 1981 .

[24]  A. Alessandri,et al.  Can COMT Inhibitors Improve Cognitive Functions in Patients with Parkinson’s Disease? , 2000 .

[25]  P. Goldman-Rakic,et al.  Modulation of memory fields by dopamine Dl receptors in prefrontal cortex , 1995, Nature.

[26]  R. Coppola,et al.  Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. , 2003, Archives of general psychiatry.

[27]  T. Salthouse,et al.  Executive functioning as a potential mediator of age-related cognitive decline in normal adults. , 2003, Journal of experimental psychology. General.

[28]  L. Nilsson,et al.  Adult Age Differences in Tower of Hanoi Performance: Influence From Demographic and Cognitive Variables , 2001 .

[29]  A. Nieoullon.  Dopamine and the regulation of cognition and attention , 2002, Progress in Neurobiology.

[30]  R. Dixon,et al.  Age-related cognitive deficits mediated by changes in the striatal dopamine system. , 2000, The American journal of psychiatry.

[31]  A. Dagher,et al.  Mapping the network for planning: a correlational PET activation study with the Tower of London task. , 1999, Brain : a journal of neurology.

[32]  J. Holden,et al.  Age‐dependent decline of dopamine D1 receptors in human brain: A PET study , 1998, Synapse.

[33]  N. Volkow,et al.  Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. , 1998, The American journal of psychiatry.

[34]  Daniel Durstewitz,et al.  The computational role of dopamine D1 receptors in working memory , 2002, Neural Networks.

[35]  T. Robbins,et al.  Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat , 1999, Neuroscience.

[36]  B. Kolachana,et al.  Catechol-O-Methyltransferase Genotype and Dopamine Regulation in the Human Brain , 2003, The Journal of Neuroscience.

[37]  P. Rabbitt.  Introduction: Methodologies and models in the study of executive function , 2004 .

[38]  M. J. Emerson,et al.  The Unity and Diversity of Executive Functions and Their Contributions to Complex “Frontal Lobe” Tasks: A Latent Variable Analysis , 2000, Cognitive Psychology.

[39]  M. Egan,et al.  Prefrontal neurons and the genetics of schizophrenia , 2001, Biological Psychiatry.

[40]  R. Depue,et al.  Facilitation of Working Memory in Humans by a D2 Dopamine Receptor Agonist , 1992, Journal of Cognitive Neuroscience.

[41]  N. Raz,et al.  Age-related deficits in generation and manipulation of mental images: II. The role of dorsolateral prefrontal cortex. , 1999, Psychology and aging.

[42]  M. J. Emerson,et al.  ASSESSMENT OF EXECUTIVE FUNCTIONS IN CLINICAL SETTINGS: PROBLEMS AND RECOMMENDATIONS , 2000, Seminars in speech and language.

[43]  Pekka T. Männistö,et al.  Catechol-O-Methyltransferase , 1996, Encyclopedia of Molecular Pharmacology.

[44]  A. Malhotra,et al.  A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. , 2002, The American journal of psychiatry.

[45]  N. Volkow,et al.  Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. , 1998, The American journal of psychiatry.

[46]  L. Nyberg,et al.  The betula prospective cohort study: Memory, health, and aging , 1997 .

[47]  Jordan Grafman,et al.  Handbook of Neuropsychology , 1991 .

[48]  P. Rabbitt,et al.  Methodology of Frontal and Executive Function , 1999 .

[49]  Robert M Bilder,et al.  Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. , 2004, The American journal of psychiatry.

[50]  Karl G. Jöreskog,et al.  Lisrel 8: User's Reference Guide , 1997 .

[51]  P. Arner,et al.  Large-scale genotyping of single nucleotide polymorphisms by Pyrosequencingtrade mark and validation against the 5'nuclease (Taqman((R))) assay. , 2002, Human mutation.

[52]  A. Diamond,et al.  Genetic and neurochemical modulation of prefrontal cognitive functions in children. , 2004, The American journal of psychiatry.

[53]  E. Phelps,et al.  FMRI of the prefrontal cortex during overt verbal fluency , 1997, Neuroreport.

[54]  U. Staudinger,et al.  Life Span Theory in Developmental Psychology , 2007 .

[55]  Monica Luciana,et al.  Dopaminergic Modulation of Working Memory for Spatial but Not Object Cues in Normal Humans , 1997, Journal of Cognitive Neuroscience.